查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519307

紅景天補充劑的全球市場 - 全球產業分析、規模、佔有率、成長、趨勢、預測（2031）- 依格式、依銷售管道、依地區

Rhodiola Rosea Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著全球心理健康意識的提高，對天然補充劑（如以其適應原特性而聞名的紅景天）的需求預計將顯著成長。紅景天補充劑的市場規模預計將從2024年的17,424,000美元成長到2031年的33,428,000美元，年複合成長率穩定在9.80%。

世界各地精神健康障礙（尤其是憂鬱症和焦慮症）的盛行率上升。據世界衛生組織（WHO）表示，數以百萬計的成年人患有憂鬱症，這是全世界殘疾的主要原因。精神障礙的增加是由多種因素造成的，包括遺傳傾向、創傷經驗以及身心健康之間複雜的相互關係。例如，癌症、糖尿病、心血管疾病等慢性疾病往往會導致憂鬱症，進一步加劇心理健康危機。對心理健康問題的認識提高以及圍繞心理健康討論的恥辱感的減少也促使更多的人尋求幫助，尋求補充劑來支持他們的心理健康。

紅景天被歸類為適應原，是一種幫助身體抵抗壓力的天然物質。適應原透過穩定生理過程和促進體內平衡來減少壓力源對身體的影響。研究表明，紅景天可刺激大腦中的血清素和多巴胺活性，促進健康的情緒和神經功能。此外，紅景天還可以增強身體耐力、預防高山症、調節血壓並保護肝臟免受損害。這些多方面的好處使紅景天成為尋求天然補充劑以改善整體健康的消費者的熱門選擇。越來越多的科學證據支持紅景天在控制壓力和提振情緒方面的有效性，也推動了市場需求。

本報告調查了全球紅景天補充劑市場，並提供了市場概況，以及依格式、銷售管道、區域劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第1章 執行摘要

第2章 市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第3章 2019-2031年全球紅景天補充品市場展望

  • 2019-2031年全球紅景天補充品市場展望，依形式、價值（十億美元）
  • 2019-2031年全球紅景天補充品市場展望，依銷售管道劃分，價值（十億美元）
  • 2019-2031年全球紅景天補充品市場前景，依地區、價值（十億美元）

第4章 北美紅景天補充品市場展望，2019-2031

第5章 歐洲紅景天補充品市場展望，2019-2031

第6章 亞太地區紅景天補充品市場展望，2019-2031

第7章 拉丁美洲紅景天補充品市場展望，2019-2031

第8章 中東與非洲紅景天補充品市場展望，2019-2031

第9章 競爭態勢

  • 按製造商和銷售管道劃分的熱圖
  • 2024年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • NutraChamps
    • Now Foods
    • Nature's Way
    • Gaia Herbs
    • BulkSupplements
    • Jarrow Formulas
    • Absorb Health
    • Thorne
    • Perfect Supplements
    • Pure Encapsulations
    • Micro Ingredients

第10章 附錄

簡介目錄

Fairfield Market Research has recently unveiled a comprehensive analysis of the Rhodiola Rosea Supplements market, highlighting significant growth prospects over the coming decade. As mental health awareness rises globally, the demand for natural supplements like Rhodiola Rosea, known for its adaptogenic properties, is expected to witness substantial growth. The market is projected to grow from a value of $17.424 million in 2024 to $33.428 million by 2031, representing a robust compound annual growth rate (CAGR) of 9.80%.

Mental Health Crisis Driving Supplement Demand

The prevalence of mental health disorders, particularly depression and anxiety, is escalating worldwide. According to the World Health Organization, millions of adults suffer from depression, a leading cause of disability globally. The rise in mental disorders can be attributed to a variety of factors, including genetic predispositions, traumatic experiences, and the complex interrelation between physical and mental health. For instance, chronic illnesses such as cancer, diabetes, and cardiovascular diseases often lead to depression, further exacerbating the mental health crisis. The increasing recognition of mental health issues and the stigma reduction surrounding mental health discussions have also contributed to more individuals seeking help and, consequently, supplements that support mental well-being.

Adaptogenic Properties of Rhodiola Rosea

Rhodiola Rosea is classified as an adaptogen, a natural substance that helps the body resist stress. Adaptogens work by stabilizing physiological processes and promoting homeostasis, thereby reducing the impact of stressors on the body. Research indicates that Rhodiola Rosea stimulates serotonin and dopamine activity in the brain, promoting healthy emotional and neurological functioning. Additionally, Rhodiola Rosea is known to enhance physical endurance, prevent high-altitude sickness, regulate blood pressure, and protect the liver from damage. These multifaceted benefits have made Rhodiola Rosea a popular choice among consumers seeking natural supplements to improve their overall well-being. The growing body of scientific evidence supporting the efficacy of Rhodiola Rosea in managing stress and enhancing mood further propels its demand in the market.

Market Expansion Due to Rising Health Consciousness

The market for Rhodiola Rosea Supplements is expected to expand as consumers become more aware of the importance of mental health. The growing health consciousness among individuals and the demand for natural supplements to enhance physical endurance and mental capacity are key drivers of market growth. The shift towards preventive healthcare, where individuals take proactive steps to maintain their health and well-being, has significantly contributed to the popularity of natural supplements. Rhodiola Rosea, with its adaptogenic properties, fits well into this trend as a natural remedy to support mental health and overall wellness.

Regional Insights: Europe and the United States

Europe held a significant market share in recent years and is projected to experience robust growth. Factors contributing to this growth include the high prevalence of chronic depression and the substantial impact of depression on chronic sick leaves. European consumers are increasingly turning to natural supplements like Rhodiola Rosea due to the adverse side effects of conventional medications. The increasing adoption of natural and holistic approaches to health in European countries, coupled with the rising awareness of the benefits of adaptogens, is expected to drive the market for Rhodiola Rosea Supplements in the region. Additionally, regulatory support for natural health products in Europe provides a conducive environment for market growth.

In the United States, depression is a prevalent mental disorder, with a significant portion of the population experiencing at least one episode of depression annually. The surge in depression cases over the past decade is attributed to growing feelings of helplessness, economic distress, and societal pressures. The COVID-19 pandemic has further exacerbated the mental health crisis, leading to increased cases of anxiety and depression. With increased government spending on mental health programs and a preference for natural supplements over conventional medicines, the U.S. market for Rhodiola Rosea Supplements is anticipated to expand significantly during the forecast period. The growing trend towards self-care and the rising popularity of dietary supplements that promote mental health are expected to be key factors driving market growth in the United States.

Key Market Players:

  • NutraChamps
  • Now Foods
  • Nature's Way
  • Gaia Herbs
  • BulkSupplements
  • Jarrow Formulas
  • Absorb Health
  • Thorne
  • Perfect Supplements
  • Pure Encapsulations
  • Micro Ingredients

Market Segmentation

By Form:

  • Capsule
  • Powder

By Sales Channels:

  • Online Sales
  • Retail Sales

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Rhodiola Rosea Supplements Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 3.1. Global Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Capsule
      • 3.1.1.2. Powder
  • 3.2. Global Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Online Sales
      • 3.2.1.2. Retail Sales
  • 3.3. Global Rhodiola Rosea Supplements Market Outlook, by Region, Value (US$ Bn), 2019-2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 4.1. North America Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Capsule
      • 4.1.1.2. Powder
  • 4.2. North America Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Online Sales
      • 4.2.1.2. Retail Sales
  • 4.3. North America Rhodiola Rosea Supplements Market Outlook, by Country, Value (US$ Bn), 2019-2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 4.3.1.2. U.S. Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 4.3.1.3. Canada Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 4.3.1.4. Canada Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 5.1. Europe Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Capsule
      • 5.1.1.2. Powder
  • 5.2. Europe Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Online Sales
      • 5.2.1.2. Retail Sales
  • 5.3. Europe Rhodiola Rosea Supplements Market Outlook, by Country, Value (US$ Bn), 2019-2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.2. Germany Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.3. U.K. Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.4. U.K. Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.5. France Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.6. France Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.7. Italy Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.8. Italy Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.9. Turkey Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.10. Turkey Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.11. Russia Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.12. Russia Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 5.3.1.13. Rest of Europe Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 5.3.1.14. Rest of Europe Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031

6. Asia Pacific Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 6.1. Asia Pacific Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Capsule
      • 6.1.1.2. Powder
  • 6.2. Asia Pacific Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Online Sales
      • 6.2.1.2. Retail Sales
  • 6.3. Asia Pacific Rhodiola Rosea Supplements Market Outlook, by Country, Value (US$ Bn), 2019-2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.2. China Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 6.3.1.3. Japan Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.4. Japan Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 6.3.1.5. South Korea Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.6. South Korea Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 6.3.1.7. India Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.8. India Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 6.3.1.9. Southeast Asia Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.10. Southeast Asia Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 6.3.1.11. Rest of Asia Pacific Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 6.3.1.12. Rest of Asia Pacific Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031

7. Latin America Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 7.1. Latin America Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Capsule
      • 7.1.1.2. Powder
  • 7.2. Latin America Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Online Sales
      • 7.2.1.2. Retail Sales
  • 7.3. Latin America Rhodiola Rosea Supplements Market Outlook, by Country, Value (US$ Bn), 2019-2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 7.3.1.2. Brazil Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 7.3.1.3. Mexico Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 7.3.1.4. Mexico Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 7.3.1.5. Argentina Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 7.3.1.6. Argentina Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 7.3.1.7. Rest of Latin America Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 7.3.1.8. Rest of Latin America Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031

8. Middle East & Africa Rhodiola Rosea Supplements Market Outlook, 2019-2031

  • 8.1. Middle East & Africa Rhodiola Rosea Supplements Market Outlook, by Form, Value (US$ Bn), 2019-2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Capsule
      • 8.1.1.2. Powder
  • 8.2. Middle East & Africa Rhodiola Rosea Supplements Market Outlook, by Sales Channels, Value (US$ Bn), 2019-2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Online Sales
      • 8.2.1.2. Retail Sales
  • 8.3. Middle East & Africa Rhodiola Rosea Supplements Market Outlook, by Country, Value (US$ Bn), 2019-2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 8.3.1.2. GCC Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 8.3.1.3. South Africa Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 8.3.1.4. South Africa Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 8.3.1.5. Egypt Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 8.3.1.6. Egypt Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 8.3.1.7. Nigeria Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 8.3.1.8. Nigeria Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031
      • 8.3.1.9. Rest of Middle East & Africa Rhodiola Rosea Supplements Market by Form, Value (US$ Bn), 2019-2031
      • 8.3.1.10. Rest of Middle East & Africa Rhodiola Rosea Supplements Market by Sales Channels, Value (US$ Bn), 2019-2031

9. Competitive Landscape

  • 9.1. Manufacturer vs by Sales Channels Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. NutraChamps
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Now Foods
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Nature's Way
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Gaia Herbs
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. BulkSupplements
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Jarrow Formulas
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Absorb Health
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Thorne
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Perfect Supplements
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Pure Encapsulations
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Micro Ingredients
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations